Avidity Biosciences (RNAM) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2026-04-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: NZ$0.92 M
• Last 12 months FTD volume: NZ$46.23 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNAM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNAM) - since 2020

Avidity Biosciences (RNAM) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$52.65 M	NZ$0.14 B	🇺🇸 USA
GSK plc GSK	NZ$43.59 M	NZ$0.24 B	🇬🇧 UK
Sarepta Therapeutics SRPT	NZ$4.41 M	NZ$20.61 M	🇺🇸 USA
PTC Therapeutics PTCT	NZ$8.31 M	NZ$22.2 M	🇺🇸 USA
Fate Therapeutics FATE	NZ$0.01 M	NZ$1.04 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	NZ$0.01 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	NZ$2.14 M	NZ$2.71 M	🇺🇸 USA